Clinical Trials Browser

Completed × Recurrence × ivosidenib × Clear all

NCT04176393 2023-02-13

A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation

Phase 1 Completed

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute